Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.630
-0.150 (-5.40%)
Mar 12, 2026, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $116.47 million as of March 12, 2026. Its market cap has decreased by -23.08% in one year.
Market Cap
116.47M
Enterprise Value
97.18M
1-Year Change
-23.08%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $116.47M, a decrease of -17.80%. That is a compound annual growth rate of -6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 123.11M | -24.94% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 127.42M |
| Black Diamond Therapeutics | 127.05M |
| TuHURA Biosciences | 126.91M |
| Alpha Cognition | 125.67M |
| Equillium | 119.66M |
| Precision BioSciences | 119.16M |
| Inovio Pharmaceuticals | 117.48M |
| Korro Bio | 117.16M |